2023-01-25 09:00:00

Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor

Logo Benzinga
Benzinga
By Globe Newswire

- Claus Andersson, PhD, joins Rewinds Board of Directors

Leuven, Belgium, January 25, 2023 --- Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated diseases, today announced that it has raised additional funding, with Sunstone Life Science Ventures A/S joining as a new investor and with participation of existing investors Boehringer Ingelheim Venture Fund, M. Ventures, PMV, Gemma Frisius Fonds, and CD3/ KU Leuven.

Claus Andersson, PhD, General Partner at Sunstone Life Science Ventures A/S, will join Rewind Therapeutics Board of Directors. Financial details of the transaction were not disclosed.

The proceeds will be used to advance Rewind Therapeutics lead program into clinical development and further broaden the Companys pipeline of drug candidates designed to restore the remyelination function of the central nervous system (CNS). Myelin forms a protective layer around neurons and is essential for their proper functioning. Neurodegenerative disorders such as multiple sclerosis are associated with a damaged, deteriorating myelin sheath, which ultimately leads to a range of symptoms such as depression, anxiety, irritability, and even death due to a breakdown of the vital neurological functions.

Continue read on benzinga.com

Logo GlobeNewswire
SciencePress Release2023-01-24 21:01:00
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo GlobeNewswire
SciencePress Release2023-01-24 11:00:00
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0), an autologous stem cell therapy company,...

Logo GlobeNewswire
SciencePress Release2023-01-24 21:25:00
REDWOOD CITY, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on developing...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG. |. OTCQB: PSYGF ) (Psyence or the Company ), a life science biotechnology company...

Logo GlobeNewswire
SciencePress Release2023-01-25 09:00:00
HANNOVER, Germany, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vakzine Projekt Management GmbH (VPM), a German drug development consultancy and service provider...

Logo PR Newswire
HealthPress Release2023-01-24 12:17:00
Emerging Market Leader Continues to Execute on Successful Growth Strategy JACKSONVILLE, Fla., Jan. 24, 2023 /PRNewswire/ -- ReviveHealth, a whole health and...

Logo GlobeNewswire
HealthPress Release2023-01-24 14:00:00
Long-standing, Employee-driven Support of Philanthropic Efforts Grows 20% Year-Over-Year BOWIE, Md., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Inovalon, a leading...

Logo NewsFileCorp
Press Release2023-01-24 13:39:00
Toronto, Ontario--(Newsfile Corp. - January 24, 2023) - Stratabound Minerals Corp. (TSXV: SB) (OTCQB: SBMIF) ("Stratabound" or the "Company") announces it...

Logo PR Newswire
Further investment by Wilco Faessen of WhistlePig, Guillaume Cuvelier of SVEDKA Vodka and Davos Brands, Paul Hletko of FEW Spirits, and Spirits Investment...

Logo PR Newswire
HealthPress Release2023-01-24 14:30:00
Atlas medical technologies GmbH strengthens equity by 2.4 million euros in Series A. The German medical technology company uses the capital increase for...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 10:00:00
Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:30:00
Atlas medical technologies GmbH strengthens equity by 2.4 million euros in Series A. The German medical technology company uses the capital increase for...

Logo PR Newswire
TechnologyPress Release2023-01-24 14:05:00
SAN FRANCISCO, Jan. 24, 2023 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical trials, announced the release of its...

Logo PR Newswire
HealthPress Release2023-01-24 11:30:00
Expansion of manufacturing facility in North Carolina will increase the number of patients who may benefit from the company's medicines INDIANAPOLIS, Jan....

Logo PR Newswire
TechnologyPress Release2023-01-24 15:00:00
These funds will be used to grow MedCrypt's engineering team in response to an increased demand for encryption and PKI solutions optimized for medical...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:30:00
SAN CARLOS, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Apexigen, Inc. (Nasdaq: APGN), a clinical-stage company focused on developing innovative antibody-based...

Logo PR Newswire
HealthPress Release2023-01-24 13:07:00
MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of...

Logo PR Newswire
HealthPress Release2023-01-24 14:09:00
Local Dental Practitioners/Entrepreneurs to Expand Anti-Aging & Wellness Franchise Throughout Region ORLANDO, Fla., Jan. 24, 2023 /PRNewswire/ --...

Logo GlobeNewswire
SciencePress Release2023-01-24 14:20:00
Immediately Accretive Addition to the Hemp/Cannabis Business with Positive EBITDA 1,276 Novel Food Applications for Cannabinoid Products to Accelerate Growth...